Results 191 to 200 of about 90,104 (295)
ABSTRACT Context Familial partial lipodystrophy type 2 (FPLD2) is a rare autosomal dominant disorder caused by pathogenic variants in the LMNA gene. The influence of parental inheritance on clinical presentation has not been fully explored. Objective To investigate the influence of maternal versus paternal inheritance of LMNA variants on the clinical ...
Donatella Gilio+12 more
wiley +1 more source
Periodontitis and metabolic diseases (diabetes and obesity): Tackling multimorbidity
Abstract Noncommunicable diseases (NCDs) are multifactorial, long‐term, chronic conditions that represent a burden to health‐care systems worldwide as they can only be controlled rather than cured; hence, they require long‐term care. With the exponential increase in NCDs, the occurrence of individuals presenting with more than one chronic disease is ...
Crystal Marruganti+2 more
wiley +1 more source
Abnormalities in the genioglossus muscle and its neuromuscular synapse in leptin-deficient male mice. [PDF]
Medharametla S+3 more
europepmc +1 more source
Summary Management of type 2 diabetes includes medications that can unintentionally increase obesity and insulin resistance. This unblinded, single‐centre, randomised controlled trial focused on rural Australian adults with type 2 diabetes (aged 18–75 and body mass index [BMI] >30 kg/m2), measuring the effectiveness of a tailored interdisciplinary ...
Giuliana O. Murfet+3 more
wiley +1 more source
Tirzepatide: a novel therapeutic approach for Alzheimer's disease. [PDF]
Alshehri GH+7 more
europepmc +1 more source
Summary Chronic stress, characterized by increased long‐term exposure to the glucocorticoid hormone cortisol, is increasingly linked to obesity development. Still, various knowledge gaps persist, including on underlying pathophysiological mechanisms. The aim of the current review is to provide the latest insights on the connection between stress and ...
Robin Lengton+4 more
wiley +1 more source
An unexpected role for the brain in the pathogenesis of diabetic ketoacidosis. [PDF]
Mirzadeh Z+3 more
europepmc +1 more source
IMPROVE 2023: The 2nd International Meeting on Pathway‐Related Obesity: Vision & Evidence
ABSTRACT A total of 150 clinicians and researchers representing 19 countries came together in person and online to participate in the highly anticipated 2nd International Meeting on Pathway‐Related Obesity: Vision & Evidence (IMPROVE), held on 13–15 December 2023 in Paris, France.
Karine Clément+19 more
wiley +1 more source
Bioinformatic Analysis of the Leptin-Ob-R Interface: Structural Modeling, Thermodynamic Profiling, and Stability in Diverse Microenvironments. [PDF]
Ortega-López GI+3 more
europepmc +1 more source
ABSTRACT Obesity appears to be associated with improved health outcomes in patients with sepsis, a phenomenon termed the obesity paradox. However, the potential influence of varying operational definitions of obesity on clinical outcomes within this paradox remains inadequately characterised.
Efris Kartikasari+2 more
wiley +1 more source